The British Journal of Psychiatry (2006) 188: 410-415. doi: 10.1192/bjp.bp.105.010470
© 2006 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by WIJKSTRA, J.
Right arrow Articles by NOLEN, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WIJKSTRA, J.
Right arrow Articles by NOLEN, W. A.

REVIEW ARTICLE

Pharmacological treatment for unipolar psychotic depression

Systematic review and meta-analysis

JAAP WIJKSTRA, MD

Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Centre, Utrecht, The Netherlands

JEROEN LIJMER, PhD

Department of Psychiatry, Waterland Hospital, Purmerend, The Netherlands

FERDI J. BALK, MD

Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Centre, Utrecht, The Netherlands

JOHN R. GEDDES, MD, FRCPsych

Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK

WILLEM A. NOLEN, PhD

University Medical Centre Groningen, Department of Psychiatry, Groningen, The Netherlands

Correspondence: Dr J. Wijkstra, University Medical Centre Utrecht, HP B01.206, PO Box 85500, 3508 GA, Utrecht, The Netherlands. E-mail: j.wijkstra{at}azu.nl

Declaration of interest J.W. and W.N. are currently conducting a randomised controlled trial in patients with unipolar psychotic depression, which is financially supported by Wyeth and AstraZeneca.These organisations also financially supported the literature search for this review.

Background The optimal pharmacological treatment of unipolar psychotic depression is uncertain.

Aims To compare the clinical effectiveness of pharmacological treatments for patients with unipolar psychotic depression.

Method Systematic review and meta-analysis of randomised controlled trials.

Results Ten trials were included in the review. We found no evidence that the combination of an antidepressant with an antipsychotic is more effective than an antidepressant alone.This combination was statistically more effective than an antipsychotic alone.

Conclusions Antidepressant monotherapy and adding an antipsychotic if the patient does not respond, or starting with the combination of an antidepressant and an antipsychotic, both appear to be appropriate options for patients with unipolar psychotic depression.However, clinically the balance between risks and benefits may suggest the first option should be preferred for many patients. Starting with an antipsychotic alone appears to be inadequate.


Related articles in BJP:

Highlights of this issue
SUKHWINDER S. SHERGILL
BJP 2006 188: 401-a17. [Full Text]  

PETER TYRER
BJP 2006 188: 500. [Full Text]  



This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
B. S. Meyers, A. J. Flint, A. J. Rothschild, B. H. Mulsant, E. M. Whyte, C. Peasley-Miklus, E. Papademetriou, A. C. Leon, M. Heo, and for the STOP-PD Group
A Double-blind Randomized Controlled Trial of Olanzapine Plus Sertraline vs Olanzapine Plus Placebo for Psychotic Depression: The Study of Pharmacotherapy of Psychotic Depression (STOP-PD)
Arch Gen Psychiatry, August 1, 2009; 66(8): 838 - 847.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Ment. HealthHome page
A. Cipriani and C. Barbui
Review: antidepressant plus antipsychotic increases clinical response rates in psychotic depression
Evid. Based Ment. Health, February 1, 2007; 10(1): 10 - 10.
[Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
J. J. Vattakatuchery
Drug treatment for psychotic depression
The British Journal of Psychiatry, October 1, 2006; 189(4): 383 - 383.
[Full Text] [PDF]

eLetters:

Read all eLetters

Psychotic depression and ‘multi-aminergic’ treatment strategies
Peter K Gillman
BJP Online, 4 May 2006 [Full text]